Investors in Acadia Healthcare Company, Inc. (ACHC) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $65 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. ...

Acadia Healthcare Company (ACHC) 2025 Conference Summary Industry Overview - Acadia Healthcare is one of the largest behavioral health providers in the US, operating a network of 270 facilities with approximately 12,000 beds across 39 states and Puerto Rico, serving over 80,000 patients daily [6][7][8]. Key Financial Performance - The company reported that revenue, EBITDA, volume, revenue per day, and margins were all in line with guidance, with EBITDA at the high end of the range [2][3]. - Acadia added 378 newly licensed beds in Q1 and reaffirmed its full-year financial guidance for both revenue and adjusted EBITDA [3][4]. Demand and Growth Outlook - Consistent demand is observed across all four lines of business, with a significant opportunity in the behavioral health sector due to an estimated 75,000 additional beds needed in the US to meet demand [6][7]. - The company is in a period of record growth, expecting to add 800 to 1,000 beds in 2025, with nearly half already achieved in Q1 [10][11]. - The Comprehensive Treatment Centers (CTCs) segment is expected to grow mid-single digits over the next few years, with a strong demand for opioid use disorder treatment [9][15]. Operational Insights - The average cost per new facility bed is estimated at $500,000 to $550,000, with a target breakeven period of 12 to 13 months and expected maturity occupancy of 80% to 85% within three to five years [12][13]. - The company is focused on tuck-in M&A to acquire existing CTCs, which is a fragmented part of healthcare, enhancing growth and efficiency [18]. Policy and Regulatory Environment - Acadia is monitoring the implications of the opioid settlement funds, with $50 billion available but only a small percentage reaching states and counties [19][20]. - The company is optimistic about the potential impact of the reconciliation bill on access to high acuity mental health care, which could mitigate costs in other healthcare areas [24][25]. Pricing and Revenue Guidance - The company anticipates low single-digit pricing growth, with supplemental payments being a significant factor in revenue projections [46][47]. - For 2025, Acadia expects revenue growth of 6%, but EBITDA is projected to decline year-over-year due to various headwinds, including supplemental payment reductions and underperforming facilities [52][53]. Challenges and Risks - The company faces challenges from underperforming facilities, which are expected to impact EBITDA by approximately $20 million for the year [34][38]. - There is ongoing concern regarding potential policy changes and their impact on Medicaid access and reimbursement rates [26][30]. Conclusion - Acadia Healthcare is positioned for growth in the behavioral health sector, with strong demand and strategic plans for bed additions and acquisitions. However, it must navigate regulatory challenges and operational headwinds to achieve its financial targets [41][44].

Core Viewpoint - Acadia Healthcare Company, Inc. (ACHC) reported mixed financial results for the first quarter, with adjusted earnings per share beating estimates but showing a significant year-over-year decline, while total revenues showed slight growth [1][2]. Financial Performance - Adjusted first-quarter earnings were 40 cents per share, exceeding the Zacks Consensus Estimate by 14.3%, but down 52.4% year over year [1]. - Total revenues increased by 0.3% year over year to $770.5 million, aligning with consensus expectations [1]. - Same-facility revenues rose 2.1% year over year to $759.7 million, although this fell short of the estimated $763.1 million [3]. - Total adjusted EBITDA decreased by 22.8% year over year to $134.2 million, slightly below the estimate of $134.9 million [4]. Operational Metrics - Patient days improved by 2.2% year over year, contributing to increased admissions, which grew by 2.1% [3]. - Revenue per patient day declined by 0.2% year over year, missing the growth estimate of 2% [3][4]. - Total expenses rose by 13.1% year over year to $757 million, exceeding the estimate of $744.6 million, driven by higher salaries, wages, benefits, and operating costs [5]. Cash and Debt Position - As of March 31, 2025, cash and cash equivalents increased to $91.2 million from $76.3 million at the end of 2024 [5]. - Total assets grew to $6.1 billion, while long-term debt rose to $2.2 billion from $1.9 billion at the end of 2024 [6]. - Total equity decreased by 1% to $3 billion, with a net leverage ratio of approximately 3.2 [6]. Share Repurchase and Guidance - Management authorized a share repurchase program for up to $300 million, with $47.3 million worth of shares repurchased in the first quarter [7]. - The company reaffirmed its 2025 guidance, projecting revenues between $3.3 billion and $3.4 billion, adjusted EBITDA between $675 million and $725 million, and adjusted EPS between $2.50 and $2.80 [8]. Future Projections - Interest expenses are expected to remain between $130 million and $140 million, with depreciation and amortization expenses projected at $175 million to $185 million [9]. - Operating cash flows are forecasted to be in the range of $460 million to $510 million, with expansion capital expenditures anticipated between $525 million and $575 million [9]. - Management estimates bed additions between 800 and 1,000 in 2025 [10].

Acadia Healthcare Company (ACHC) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Company Participants Brian Farley - EVP - General Counsel & SecretaryChristopher H. Hunter - CEOHeather Dixon - Chief Financial OfficerA.J. Rice - Managing DirectorWhit Mayo - Senior Managing DirectorJohn Ransom - Managing Director, Director of Healthcare ResearchAndrew Mok - DirectorGabrielle Ingoglia - Equity Research Associate Conference Call Participants Brian Tanquilut - Equity Research Analyst - Healthcare ServicesPito Chi ...

Acadia Healthcare Company (ACHC) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Speaker0 After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your telephone keypad. To withdraw your question, please press star then 2. On today's call, we ask that you please limit yourself to one question and one follow-up during q and a. Also, please be aware that today's call is being recorded. I would now like to turn the call over to Brian Farley, Gene ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.72 per share when it actually produced earnings of $0.64, delivering a surprise of ...

ACADIA HEALTHCARE REPORTS FIRST QUARTER 2025 RESULTS AFFIRMS FULL YEAR 2025 GUIDANCE Exhibit 99 FRANKLIN, Tenn. (May 12, 2025) – Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Adjusted income attributable to Acadia and Adjusted EBITDA are non-GAAP financial measures. A reconciliation of all non- GAAP financial measures in this press release begins on page 9. First Quarter R ...

For the quarterly period ended March 31, 2025 or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) (State o ...

Core Viewpoint - Acadia Healthcare Company, Inc. (ACHC) is expected to report first-quarter 2025 results on May 12, with earnings estimated at 42 cents per share and revenues at $770.5 million, indicating a year-over-year earnings decline of 50% but a slight revenue growth of 0.3% [1][2]. Financial Estimates - First-quarter earnings estimates have declined by 8 cents per share over the past 60 days, reflecting a significant year-over-year decrease [2]. - For the full year 2025, the revenue estimate for Acadia Healthcare is $3.33 billion, representing a year-over-year increase of 5.7%, while the EPS estimate is $2.76, indicating a decline of 16.4% year-over-year [2]. Recent Performance - Acadia Healthcare has beaten earnings estimates in three of the last four quarters, with an average surprise of negative 0.4% [3]. Earnings Prediction Model - The current model does not predict an earnings beat for Acadia Healthcare, as it has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [4]. Revenue Drivers - Revenue per patient day is estimated to rise by 2% year-over-year, and revenues from Residential Treatment Centers are expected to increase by 9.7% from $85.6 million a year ago [6]. - U.S. same-facility admissions are projected to show a marginal increase, while revenues from Specialty Treatment Facilities are expected to rise by 0.1% from $143.8 million [7]. Expense Concerns - Rising expenses are anticipated to impact profit levels, with total expenses expected to increase by more than 11% due to higher salaries, wages, benefits, and other operating costs [8]. - Supply costs are also expected to rise due to increased utilization [8]. Revenue Declines in Specific Areas - Revenues from Acute Inpatient Psychiatric Facilities are projected to decrease by 1.3% from $401.1 million, and same-facility patient days are expected to decline by 1.1% year-over-year [9]. - Comprehensive Treatment Centers' revenues are estimated to fall by 0.5% from $132.2 million [9].

Group 1 - Acadia Healthcare Company, Inc. (ACHC) has been added to the Zacks Rank 5 (Strong Sell) List due to a 17.4% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Blackbaud, Inc. (BLKB) is also on the Zacks Rank 5 (Strong Sell) List, with a 6.7% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Cable One, Inc. (CABO) has been included in the Zacks Rank 5 (Strong Sell) List, with an 8.5% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2]